Labor PainNCT04141527
Spinal Sufentanil for Obstetric Analgesia
An observational study of Labor Pain, run by Lund University.
Trial summary
Background: This descriptive study was designed to evaluate effects and adverse effects of spinal sufentanil for relief of labor pain in primi- and multiparous women. Methods: The retrospective study design was approved by the regional Human Research Ethics Review Board, Lund, Sweden (Dnr 2015/687). Read more about this study
- Who is it for?
- Any age, women only
- Conditions the study is for
- Labor Pain
- What is being tested?
- Spinal analgesia
- Type of treatment
- Injection or infusion, Surgery or procedure
- How many people
- 164 participants
- Where
- No sites listed yet
- Study dates
- 15 Jun 2016to 21 Jun 2017
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- Women only
- No healthy volunteers
- Child, Adult, Older adult
Study population: Primi- and multiparous obstetrical patients at the maternity ward of the Central Hospital in Kristianstad, Sweden, between 7th January 2013 and 29th July 2016
Who may be able to join
- Intrathecal sufentanil for labor pain
Who cannot join
- Demographic, obstetrical or neonatal data is missing
About this study
Official title: Spinal Sufentanil for Relief of Labor Pain in Primi- and Multiparous Parturients
Background: This descriptive study was designed to evaluate effects and adverse effects of spinal sufentanil for relief of labor pain in primi- and multiparous women.
Methods: The retrospective study design was approved by the regional Human Research Ethics Review Board, Lund, Sweden (Dnr 2015/687). The investigators included 164 (82 primi- and 82 multiparous) obstetrical patients given 10 µg of intrathecal sufentanil for labor pain. Any maternal hypotension, third- or fourth-degree perineal tear, intrapartum Cesarean section, abnormal fetal heart rate, low Apgar score, use of neonatal intensive care, postdural puncture headache, epidural blood patch, and breastfeeding problem was recorded. Major outcome measures were maternal satisfaction with pain relief, and provision of supplementary analgesia.
Read the detailed description
A total sample size of 150 parturients had been calculated to enable differences of at least 20 % versus 5.0 % in proportions of obstetrical and neonatal problems between (equal numbers of) primi- and multiparous mothers to be statistically confirmed with 80 % power and 95 % probability.
Descriptive parametric data is reported as mean ± standard deviation (SD), and descriptive non-parametric data as median with interquartile range (IQR). Proportions are reported in percent with 95 % confidence interval (CI).
Parametric data was compared with two-tailed unpaired student's t-test, and non-parametric data with the Mann-Whitney U-test. Proportions were analyzed with two-tailed Fisher's exact test.
Probability (P) values at < 0.05 were considered statistically significant.
- Conditions
- Labor Pain
- Being tested
- Spinal analgesia
- Keywords
- Labor, Intrathecal sufentanil, Obstetrical, Spinal analgesia
- Medical subject headings
- Labor Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Spinal analgesiaProcedure or surgery
Spinal analgesia (SA) was provided by a resident or specialist anaesthesiologist with the patient in a sitting or a recumbent position. A pencil-point needle, primarily 27 G (0.4 mm), otherwise 25 G (0.5 mm), was used for transdermal intrathecal administration of 2.0 ml of sufentanil 5 µg/ml (Sufenta®, Janssen-Cilag AB, Solna, Sweden) at low-lumbar level. Blood pressure was recorded before, immediately after, and at five-minute intervals for 20 minutes after the block. Any decrease in systolic pressure to <100 mmHg or a decrease >20% from the baseline level despite infusion of crystalloid was defined to indicate maternal hypotension.
| Study group | Role | What they receive |
|---|---|---|
| Primiparous women | 82 primiparous obstetrical patients given intrathecal sufentanil for labor pain. Receives: Procedure: Spinal analgesia | |
| Multiparous women | 82 multiparous obstetrical patients given intrathecal sufentanil for labor pain. Receives: Procedure: Spinal analgesia |
What is being measured
The primary outcome is the main question the study is designed to answer.
Maternal hypotension
Any fall in systolic pressure to <100 mmHg or a decrease >20% from the baseline level
Measured: During the first 20 minutes after spinal analgesia with 5 minutes intervals
Fetal bradycardia
A decrease in FHR(fetal heart rate) to 80 beats/ min for duration of 2 or more
Measured: During the first hour after spinal analgesia
Late fetal deceleration
FHR(fetal heart rate)<FHR 40 min beats/ min below the baseline or less than 90/beats min for duration of 2 minutes or more
Measured: During the first hour after spinal analgesia
Supplementary spinal analgesia
Any use of spinal analgesia after primary spinal analgesia
Measured: 24 hours after initial spinal analgesia
Supplementary epidural analgesia
Any use of epidural analgesia after primary spinal analgesia
Measured: 24 hours after initial spinal analgesia
Instrumental delivery
Use of instrumental delivery
Measured: During childbirth
Intrapartum Cesarean section
Use of intrapartum Cesarean section
Measured: During childbirth
Third- or fourth-degree perineal tear
Rate of third- or fourth-degree perineal tear
Measured: During childbirth
Oxytocin before spinal analgesia
Any use of oxytocin before spinal analgesia
Measured: 24 hours before childbirth
Oxytocin after spinal analgesia
Any use of oxytocin after spinal analgesia
Measured: 24 hours after spinal analgesia
Maternal satisfaction with pain relief
Defined by parturient after delivery as very god, god, less satisfactory or bad
Measured: 24 hours after spinal analgesia
Postspinal dural puncture headache
Rate of postspinal dural puncture headache
Measured: 48 hours after spinal analgesia
Epidural blood patch
Use of epidural blood patch
Measured: 1 veek after spinal analgesia
Secondary outcomes (8)
Low Apgar score of newborn (Apgar score ≤ 7 )
Number of newborns with Apgar score ≤ 7
Measured: One minute and 5 minutes after birth
Use of neonatal intensive care
Number of newborns requiring intensive care unit
Measured: 1 week
Breastfeeding
Number of infants with breastfeeding
Measured: 1 week
Time from maternal arrival until request for SA
Time in minutes
Measured: During childbirth
Time from request for SA until arrival of anaesthesiologist
Time in minutes
Measured: During childbirth
Time from arrival of anaesthesiologist until SA
Time in minutes
Measured: During childbirth
Time from SA until maximal cervical dilation
Time in minutes
Measured: During childbirth
Time from maximal cervical dilation until delivery
Time in minutes
Measured: During childbirth
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Oct 2019
- Study start15 Jun 2016
- Primary completion25 Aug 2016
- Study completion21 Jun 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (28)Papers the sponsor has linked to this study.
- Other trials for Labor PainStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Retrospective
- Enrolment
- 164 participants (actual)
Sponsor and investigators
- Lead sponsor
- Lund University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Jonas Åkeson, Professor, Principal investigator, Lund University Skåne University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04141527
- Sponsor's protocol ID
- DNR2015/687
- Status last verified
- Sep 2020
- First submitted
- 17 Oct 2019
- Last updated
- 3 Sep 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Jones L, Othman M, Dowswell T, Alfirevic Z, Gates S, Newburn M, Jordan S, Lavender T, Neilson JP. Pain management for women in labour: an overview of systematic reviews. Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD009234. doi: 10.1002/14651858.CD009234.pub2.
PubMed 22419342Loubert C, Hinova A, Fernando R. Update on modern neuraxial analgesia in labour: a review of the literature of the last 5 years. Anaesthesia. 2011 Mar;66(3):191-212. doi: 10.1111/j.1365-2044.2010.06616.x.
PubMed 21320088Eriksson SL, Blomberg I, Olofsson C. Single-shot intrathecal sufentanil with bupivacaine in late labour--analgesic quality and obstetric outcome. Eur J Obstet Gynecol Reprod Biol. 2003 Oct 10;110(2):131-5. doi: 10.1016/s0301-2115(03)00049-6.
PubMed 12969571Campbell DC, Camann WR, Datta S. The addition of bupivacaine to intrathecal sufentanil for labor analgesia. Anesth Analg. 1995 Aug;81(2):305-9. doi: 10.1097/00000539-199508000-00017.
PubMed 7618720Sia AT, Chong JL, Chiu JW. Combination of intrathecal sufentanil 10 mug plus bupivacaine 2.5 mg for labor analgesia: is half the dose enough? Anesth Analg. 1999 Feb;88(2):362-6. doi: 10.1097/00000539-199902000-00026.
PubMed 9972757Aneiros F, Vazquez M, Valino C, Taboada M, Sabate S, Otero P, Costa J, Carceller J, Vazquez R, Diaz-Vieito M, Rodriguez A, Alvarez J. Does epidural versus combined spinal-epidural analgesia prolong labor and increase the risk of instrumental and cesarean delivery in nulliparous women? J Clin Anesth. 2009 Mar;21(2):94-7. doi: 10.1016/j.jclinane.2008.06.020.
PubMed 19329011Norris MC, Fogel ST, Conway-Long C. Combined spinal-epidural versus epidural labor analgesia. Anesthesiology. 2001 Oct;95(4):913-20. doi: 10.1097/00000542-200110000-00020.
PubMed 11605932Stocks GM, Hallworth SP, Fernando R, England AJ, Columb MO, Lyons G. Minimum local analgesic dose of intrathecal bupivacaine in labor and the effect of intrathecal fentanyl. Anesthesiology. 2001 Apr;94(4):593-8; discussion 5A. doi: 10.1097/00000542-200104000-00011.
PubMed 11379678Patel NP, Armstrong SL, Fernando R, Columb MO, Bray JK, Sodhi V, Lyons GR. Combined spinal epidural vs epidural labour analgesia: does initial intrathecal analgesia reduce the subsequent minimum local analgesic concentration of epidural bupivacaine? Anaesthesia. 2012 Jun;67(6):584-93. doi: 10.1111/j.1365-2044.2011.07045.x. Epub 2012 Mar 15.
PubMed 22420645Valensise H, Lo Presti D, Tiralongo GM, Pisani I, Gagliardi G, Vasapollo B, Frigo MG. Foetal heart rate deceleration with combined spinal-epidural analgesia during labour: a maternal haemodynamic cardiac study. J Matern Fetal Neonatal Med. 2016;29(12):1980-6. doi: 10.3109/14767058.2015.1072156. Epub 2015 Aug 28.
PubMed 26333691Patel NP, El-Wahab N, Fernando R, Wilson S, Robson SC, Columb MO, Lyons GR. Fetal effects of combined spinal-epidural vs epidural labour analgesia: a prospective, randomised double-blind study. Anaesthesia. 2014 May;69(5):458-67. doi: 10.1111/anae.12602.
PubMed 24738803Anim-Somuah M, Smyth R, Howell C. Epidural versus non-epidural or no analgesia in labour. Cochrane Database Syst Rev. 2005 Oct 19;(4):CD000331. doi: 10.1002/14651858.CD000331.pub2.
PubMed 16235275Laine K, Gissler M, Pirhonen J. Changing incidence of anal sphincter tears in four Nordic countries through the last decades. Eur J Obstet Gynecol Reprod Biol. 2009 Sep;146(1):71-5. doi: 10.1016/j.ejogrb.2009.04.033. Epub 2009 May 30.
PubMed 19482405Howell CJ, Kidd C, Roberts W, Upton P, Lucking L, Jones PW, Johanson RB. A randomised controlled trial of epidural compared with non-epidural analgesia in labour. BJOG. 2001 Jan;108(1):27-33. doi: 10.1111/j.1471-0528.2001.00012.x.
PubMed 11213000Cooper GM, MacArthur C, Wilson MJ, Moore PA, Shennan A; COMET Study Group UK. Satisfaction, control and pain relief: short- and long-term assessments in a randomised controlled trial of low-dose and traditional epidurals and a non-epidural comparison group. Int J Obstet Anesth. 2010 Jan;19(1):31-7. doi: 10.1016/j.ijoa.2009.05.004. Epub 2009 Nov 27.
PubMed 19945274
Study at a glance
From the registry record, last updated by the sponsor on 3 Sep 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Spinal Sufentanil for Relief of Labor Pain in Primi- and Multiparous Parturients
- ClinicalTrials.gov ID
- NCT04141527
- Acronym / sponsor ID
- DNR2015/687
- Conditions
- Labor Pain
- Keywords
- Labor, Intrathecal sufentanil, Obstetrical, Spinal analgesia
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 164 participants (actual)
- Lead sponsor
- Lund UniversityUniversity, hospital or other
- Study start
- 15 Jun 2016 (actual)
- Primary completion
- 25 Aug 2016 (actual)
- Study completion
- 21 Jun 2017 (actual)
- First posted
- 28 Oct 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background: This descriptive study was designed to evaluate effects and adverse effects of spinal sufentanil for relief of labor pain in primi- and multiparous women.
Methods: The retrospective study design was approved by the regional Human Research Ethics Review Board, Lund, Sweden (Dnr 2015/687). The investigators included 164 (82 primi- and 82 multiparous) obstetrical patients given 10 µg of intrathecal sufentanil for labor pain. Any maternal hypotension, third- or fourth-degree perineal tear, intrapartum Cesarean section, abnormal fetal heart rate, low Apgar score, use of neonatal intensive care, postdural puncture headache, epidural blood patch, and breastfeeding problem was recorded. Major outcome measures were maternal satisfaction with pain relief, and provision of supplementary analgesia.
Detailed description
A total sample size of 150 parturients had been calculated to enable differences of at least 20 % versus 5.0 % in proportions of obstetrical and neonatal problems between (equal numbers of) primi- and multiparous mothers to be statistically confirmed with 80 % power and 95 % probability.
Descriptive parametric data is reported as mean ± standard deviation (SD), and descriptive non-parametric data as median with interquartile range (IQR). Proportions are reported in percent with 95 % confidence interval (CI).
Parametric data was compared with two-tailed unpaired student's t-test, and non-parametric data with the Mann-Whitney U-test. Proportions were analyzed with two-tailed Fisher's exact test.
Probability (P) values at < 0.05 were considered statistically significant.
Study design
- Observational model
- Case-control
- Time perspective
- Retrospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Primiparous women | – | Procedure: Spinal analgesia82 primiparous obstetrical patients given intrathecal sufentanil for labor pain. |
| Multiparous women | – | Procedure: Spinal analgesia82 multiparous obstetrical patients given intrathecal sufentanil for labor pain. |
Who may qualify
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Primi- and multiparous obstetrical patients at the maternity ward of the Central Hospital in Kristianstad, Sweden, between 7th January 2013 and 29th July 2016
Key inclusion criteria (1 listed)
- Intrathecal sufentanil for labor pain
Key exclusion criteria (1 listed)
- Demographic, obstetrical or neonatal data is missing
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Spinal analgesiaSpinal analgesia (SA) was provided by a resident or specialist anaesthesiologist with the patient in a sitting or a recumbent position. A pencil-point needle, primarily 27 G (0.4 mm), otherwise 25 G (0.5 mm), was used for transdermal intrathecal administration of 2.0 ml of sufentanil 5 µg/ml (Sufenta®, Janssen-Cilag AB, Solna, Sweden) at low-lumbar level. Blood pressure was recorded before, immediately after, and at five-minute intervals for 20 minutes after the block. Any decrease in systolic pressure to <100 mmHg or a decrease >20% from the baseline level despite infusion of crystalloid was defined to indicate maternal hypotension. | Procedure or surgery | Multiparous women, Primiparous women |
Primary outcome
Maternal hypotension
Time frame: During the first 20 minutes after spinal analgesia with 5 minutes intervals
Any fall in systolic pressure to <100 mmHg or a decrease >20% from the baseline level
Fetal bradycardia
Time frame: During the first hour after spinal analgesia
A decrease in FHR(fetal heart rate) to 80 beats/ min for duration of 2 or more
Late fetal deceleration
Time frame: During the first hour after spinal analgesia
FHR(fetal heart rate)<FHR 40 min beats/ min below the baseline or less than 90/beats min for duration of 2 minutes or more
Supplementary spinal analgesia
Time frame: 24 hours after initial spinal analgesia
Any use of spinal analgesia after primary spinal analgesia
Supplementary epidural analgesia
Time frame: 24 hours after initial spinal analgesia
Any use of epidural analgesia after primary spinal analgesia
Instrumental delivery
Time frame: During childbirth
Use of instrumental delivery
Intrapartum Cesarean section
Time frame: During childbirth
Use of intrapartum Cesarean section
Third- or fourth-degree perineal tear
Time frame: During childbirth
Rate of third- or fourth-degree perineal tear
Oxytocin before spinal analgesia
Time frame: 24 hours before childbirth
Any use of oxytocin before spinal analgesia
Oxytocin after spinal analgesia
Time frame: 24 hours after spinal analgesia
Any use of oxytocin after spinal analgesia
Maternal satisfaction with pain relief
Time frame: 24 hours after spinal analgesia
Defined by parturient after delivery as very god, god, less satisfactory or bad
Postspinal dural puncture headache
Time frame: 48 hours after spinal analgesia
Rate of postspinal dural puncture headache
Epidural blood patch
Time frame: 1 veek after spinal analgesia
Use of epidural blood patch
8 secondary outcomes
Low Apgar score of newborn (Apgar score ≤ 7 )
Time frame: One minute and 5 minutes after birth
Use of neonatal intensive care
Time frame: 1 week
Breastfeeding
Time frame: 1 week
Time from maternal arrival until request for SA
Time frame: During childbirth
Time from request for SA until arrival of anaesthesiologist
Time frame: During childbirth
Time from arrival of anaesthesiologist until SA
Time frame: During childbirth
Time from SA until maximal cervical dilation
Time frame: During childbirth
Time from maximal cervical dilation until delivery
Time frame: During childbirth
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Sep 2020.
- Background: PubMed 22419342Jones L, Othman M, Dowswell T, Alfirevic Z, Gates S, Newburn M, Jordan S, Lavender T, Neilson JP. Pain management for women in labour: an overview of systematic reviews. Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD009234. doi: 10.1002/14651858.CD009234.pub2.
- Background: PubMed 21320088Loubert C, Hinova A, Fernando R. Update on modern neuraxial analgesia in labour: a review of the literature of the last 5 years. Anaesthesia. 2011 Mar;66(3):191-212. doi: 10.1111/j.1365-2044.2010.06616.x.
- Background: PubMed 12969571Eriksson SL, Blomberg I, Olofsson C. Single-shot intrathecal sufentanil with bupivacaine in late labour--analgesic quality and obstetric outcome. Eur J Obstet Gynecol Reprod Biol. 2003 Oct 10;110(2):131-5. doi: 10.1016/s0301-2115(03)00049-6.
- Background: PubMed 7618720Campbell DC, Camann WR, Datta S. The addition of bupivacaine to intrathecal sufentanil for labor analgesia. Anesth Analg. 1995 Aug;81(2):305-9. doi: 10.1097/00000539-199508000-00017.
- Background: PubMed 9972757Sia AT, Chong JL, Chiu JW. Combination of intrathecal sufentanil 10 mug plus bupivacaine 2.5 mg for labor analgesia: is half the dose enough? Anesth Analg. 1999 Feb;88(2):362-6. doi: 10.1097/00000539-199902000-00026.
- Background: PubMed 19329011Aneiros F, Vazquez M, Valino C, Taboada M, Sabate S, Otero P, Costa J, Carceller J, Vazquez R, Diaz-Vieito M, Rodriguez A, Alvarez J. Does epidural versus combined spinal-epidural analgesia prolong labor and increase the risk of instrumental and cesarean delivery in nulliparous women? J Clin Anesth. 2009 Mar;21(2):94-7. doi: 10.1016/j.jclinane.2008.06.020.
- Background: PubMed 11605932Norris MC, Fogel ST, Conway-Long C. Combined spinal-epidural versus epidural labor analgesia. Anesthesiology. 2001 Oct;95(4):913-20. doi: 10.1097/00000542-200110000-00020.
- Background: PubMed 11379678Stocks GM, Hallworth SP, Fernando R, England AJ, Columb MO, Lyons G. Minimum local analgesic dose of intrathecal bupivacaine in labor and the effect of intrathecal fentanyl. Anesthesiology. 2001 Apr;94(4):593-8; discussion 5A. doi: 10.1097/00000542-200104000-00011.
- Background: PubMed 22420645Patel NP, Armstrong SL, Fernando R, Columb MO, Bray JK, Sodhi V, Lyons GR. Combined spinal epidural vs epidural labour analgesia: does initial intrathecal analgesia reduce the subsequent minimum local analgesic concentration of epidural bupivacaine? Anaesthesia. 2012 Jun;67(6):584-93. doi: 10.1111/j.1365-2044.2011.07045.x. Epub 2012 Mar 15.
- Background: PubMed 26333691Valensise H, Lo Presti D, Tiralongo GM, Pisani I, Gagliardi G, Vasapollo B, Frigo MG. Foetal heart rate deceleration with combined spinal-epidural analgesia during labour: a maternal haemodynamic cardiac study. J Matern Fetal Neonatal Med. 2016;29(12):1980-6. doi: 10.3109/14767058.2015.1072156. Epub 2015 Aug 28.
- Background: PubMed 24738803Patel NP, El-Wahab N, Fernando R, Wilson S, Robson SC, Columb MO, Lyons GR. Fetal effects of combined spinal-epidural vs epidural labour analgesia: a prospective, randomised double-blind study. Anaesthesia. 2014 May;69(5):458-67. doi: 10.1111/anae.12602.
- Background: PubMed 16235275Anim-Somuah M, Smyth R, Howell C. Epidural versus non-epidural or no analgesia in labour. Cochrane Database Syst Rev. 2005 Oct 19;(4):CD000331. doi: 10.1002/14651858.CD000331.pub2.
- Statistics on breastfeeding 2014. Statistics Sweden 2016Link provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Labor Pain
Recruiting
Pain Neuroscience-Based Education for Labor Pain in Pregnant Women
Labor Pain and Anxiety
Recruiting
The Effect of Breast Milk, 10% and 20% Dextrose on Pain and Physiological Variables During Heel Puncture in Infants
Newborn Care, Pain Management
Not yet recruiting
The 90% Effective Initial Volume for Labor Analgesia Under Double Dural Puncture Epidural Technique
Labor Pain
Not yet recruiting
Initiation Ropivacaine Dose for Labor Analgesia Via Double Dural Puncture Epidural Technique
Labor Pain
Not yet recruitingObservational study
Effect of Dural Puncture Epidural Analgesia on Oxytocin in Early vs Late Labor
Labor Analgesia, Labor Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jonas Åkeson, Professor principal investigator
Lund University Skåne University Hospital
Questions about this trial
What is this clinical trial studying?
An observational study of Labor Pain, run by Lund University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Maternal hypotension (time frame: During the first 20 minutes after spinal analgesia with 5 minutes intervals). The study lists 13 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04141527, which also lists 28 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Sep 2020.